• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高 b 值扩散加权磁共振成像在肝细胞性病变中的应用:对肝细胞癌恶性程度的评估。

High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma.

机构信息

Department of Radiology, University of Yamanashi, Yamanshi, Japan.

出版信息

J Magn Reson Imaging. 2009 Nov;30(5):1005-11. doi: 10.1002/jmri.21931.

DOI:10.1002/jmri.21931
PMID:19856432
Abstract

PURPOSE

To evaluate the effectiveness of diffusion-weighted magnetic resonance imaging (DWI) in estimating the grade of malignancy of hepatocellular carcinoma.

MATERIALS AND METHODS

Dynamic contrast-enhanced computed tomography (CE-CT) and DWI (b value, 1000 s/mm(2)) were performed on 73 patients. Using DW images, the lesions were classified as "visible" or "invisible." The apparent diffusion coefficient (ADC) of the lesions was measured. Furthermore, the lesions were classified as hypervascular or iso-hypovascular using arterial phase CE-CT images. The image findings for each lesion type were compared.

RESULTS

The 73 patients had 98 hepatocellular lesions, of which 12 were histologically diagnosed as dysplastic nodules; 39, well-differentiated HCCs; 33, moderately differentiated HCCs; and 14, poorly differentiated HCCs. The mean ADC values of moderately poorly-differentiated HCCs were significantly lower than well-differentiated HCCs and dysplastic nodules (P < 0.01). On DW images, >90% of moderately (30/33) and poorly differentiated HCCs (13/14) were visible, while 51% of well-differentiated HCCs (20/39) and all dysplastic nodules were invisible. Of 22 iso-hypovascular lesions, 4 were visible on DW images and were poorly differentiated HCCs, whereas 18 were invisible and were dysplastic nodules (12/18) or well-differentiated HCCs (6/18).

CONCLUSION

A combination of hypovascularity and visibility on DW images can help distinguish poorly differentiated HCCs from low-grade hepatocellular lesions (dysplastic nodules and well-differentiated HCCs).

摘要

目的

评估弥散加权磁共振成像(DWI)在估计肝细胞癌恶性程度中的作用。

材料与方法

对 73 例患者进行了动态对比增强 CT(CE-CT)和 DWI(b 值为 1000 s/mm²)检查。在 DW 图像上,将病变分为“可见”或“不可见”。测量病变的表观弥散系数(ADC)。此外,使用动脉期 CE-CT 图像将病变分为富血管性或等血管性。比较了每种病变类型的图像表现。

结果

73 例患者共有 98 个肝细胞病变,其中 12 个组织学诊断为不典型增生结节;39 个为高分化 HCC;33 个为中分化 HCC;14 个为低分化 HCC。中低分化 HCC 的平均 ADC 值明显低于高分化 HCC 和不典型增生结节(P < 0.01)。在 DW 图像上,33 个中分化 HCC(30/33)和 14 个低分化 HCC(13/14)中超过 90%可见,而 39 个高分化 HCC(20/39)中仅有 51%可见,且均为不典型增生结节。在 22 个等血管性病变中,有 4 个在 DW 图像上可见,为低分化 HCC,而 18 个不可见,为不典型增生结节(18/18)或高分化 HCC(6/18)。

结论

低分化 HCC 具有低灌注和 DW 图像可见性的特征,有助于与低级别肝细胞病变(不典型增生结节和高分化 HCC)相鉴别。

相似文献

1
High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma.高 b 值扩散加权磁共振成像在肝细胞性病变中的应用:对肝细胞癌恶性程度的评估。
J Magn Reson Imaging. 2009 Nov;30(5):1005-11. doi: 10.1002/jmri.21931.
2
Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.钆塞酸增强肝胆期 MRI 和高 b 值扩散加权成像在慢性肝病患者中鉴别高分化肝细胞癌与良性结节
AJR Am J Roentgenol. 2011 Nov;197(5):W868-75. doi: 10.2214/AJR.10.6237.
3
Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.扩散加权磁共振成像在肝硬化肝脏中肝细胞癌和发育异常结节特征描述中的作用
J Comput Assist Tomogr. 2010 Jul;34(4):506-12. doi: 10.1097/RCT.0b013e3181da3671.
4
Diffusion-weighted magnetic resonance imaging of focal hepatic nodules in an experimental hepatocellular carcinoma rat model.实验性肝细胞癌大鼠模型中局灶性肝结节的磁共振扩散加权成像
Acad Radiol. 2007 Mar;14(3):279-86. doi: 10.1016/j.acra.2006.12.005.
5
Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.超顺磁性氧化铁增强 MRI 成像在肝硬化肝脏肝细胞癌无创成像诊断中的附加价值。
Invest Radiol. 2009 Dec;44(12):800-7. doi: 10.1097/RLI.0b013e3181bc271d.
6
Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.使用钆塞酸增强磁共振成像鉴别肝脏富血管性假病变与富血管性肝细胞癌。
Radiology. 2010 Jul;256(1):151-8. doi: 10.1148/radiol.10091885.
7
Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade.手术切除肝细胞癌的扩散加权成像:影像特征及信号强度、表观扩散系数与组织病理学分级之间的关系
AJR Am J Roentgenol. 2009 Aug;193(2):438-44. doi: 10.2214/AJR.08.1424.
8
Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization.慢性肝病患者钆塞酸增强磁共振成像中无强化低信号结节:弥散加权成像的特征分析。
Radiology. 2015 Jul;276(1):137-46. doi: 10.1148/radiol.15141350. Epub 2015 Feb 27.
9
Comparison of diffusion-weighted with T2-weighted Imaging for detection of small hepatocellular carcinoma in cirrhosis: preliminary quantitative study at 3-T.弥散加权成像与 T2 加权成像在肝硬化小肝癌检测中的比较:3T 初步定量研究。
Acad Radiol. 2010 Feb;17(2):239-43. doi: 10.1016/j.acra.2009.09.012. Epub 2009 Dec 4.
10
Diagnosis of small hepatocellular carcinoma--imaging diagnosis and significance of tumor biopsy.小肝细胞癌的诊断——影像学诊断及肿瘤活检的意义
Hepatogastroenterology. 2000 Nov-Dec;47(36):1659-62.

引用本文的文献

1
Preoperative prediction of VETC in hepatocellular carcinoma using non-Gaussian diffusion-weighted imaging at high b values: a pilot study.使用高b值非高斯扩散加权成像对肝细胞癌中静脉-肝内分流的术前预测:一项初步研究
Front Oncol. 2023 May 25;13:1167209. doi: 10.3389/fonc.2023.1167209. eCollection 2023.
2
Classification tree analysis to evaluate the most useful magnetic resonance image type in the differentiation between early and progressed hepatocellular carcinoma.分类树分析评估在鉴别早期和进展期肝细胞癌中最有用的磁共振成像类型。
Cancer Med. 2023 Apr;12(7):8018-8026. doi: 10.1002/cam4.5589. Epub 2023 Jan 22.
3
The Roles of Diffusion Kurtosis Imaging and Intravoxel Incoherent Motion Diffusion-Weighted Imaging Parameters in Preoperative Evaluation of Pathological Grades and Microvascular Invasion in Hepatocellular Carcinoma.
扩散峰度成像和体素内不相干运动扩散加权成像参数在肝细胞癌病理分级和微血管侵犯术前评估中的作用
Front Oncol. 2022 May 11;12:884854. doi: 10.3389/fonc.2022.884854. eCollection 2022.
4
Variability of radiomic features extracted from multi-b-value diffusion-weighted images in hepatocellular carcinoma.从肝细胞癌多b值扩散加权图像中提取的影像组学特征的变异性
Transl Cancer Res. 2019 Feb;8(1):130-140. doi: 10.21037/tcr.2019.01.14.
5
Diffusion-weighted Imaging of the Abdomen during a Single Breath-hold Using Simultaneous-multislice Echo-planar Imaging.腹部单次屏气同时多层面回波平面弥散加权成像。
Magn Reson Med Sci. 2023 Apr 1;22(2):253-262. doi: 10.2463/mrms.mp.2021-0087. Epub 2021 Nov 2.
6
Diagnostic accuracy of apparent diffusion coefficient (ADC) value in differentiating malignant from benign solid liver lesions: a systematic review and meta-analysis.表观扩散系数(ADC)值鉴别良恶性肝脏实性病变的诊断准确性:系统评价和荟萃分析。
Br J Radiol. 2021 Jul 1;94(1123):20210059. doi: 10.1259/bjr.20210059. Epub 2021 Jun 16.
7
Diffusion-Weighted Imaging Reflects Tumor Grading and Microvascular Invasion in Hepatocellular Carcinoma.扩散加权成像反映肝细胞癌的肿瘤分级和微血管侵犯。
Liver Cancer. 2021 Feb;10(1):10-24. doi: 10.1159/000511384. Epub 2021 Jan 27.
8
Comparative Study of Amide Proton Transfer Imaging and Intravoxel Incoherent Motion Imaging for Predicting Histologic Grade of Hepatocellular Carcinoma.酰胺质子转移成像与体素内不相干运动成像预测肝细胞癌组织学分级的比较研究
Front Oncol. 2020 Oct 29;10:562049. doi: 10.3389/fonc.2020.562049. eCollection 2020.
9
Amide Proton Transfer Imaging vs Diffusion Kurtosis Imaging for Predicting Histological Grade of Hepatocellular Carcinoma.酰胺质子转移成像与扩散峰度成像对预测肝细胞癌组织学分级的比较
J Hepatocell Carcinoma. 2020 Oct 9;7:159-168. doi: 10.2147/JHC.S272535. eCollection 2020.
10
Quantitative analysis of multiphase magnetic resonance images may assist prediction of histopathological grade of small hepatocellular carcinoma.多期磁共振图像的定量分析可能有助于预测小肝细胞癌的组织病理学分级。
Ann Transl Med. 2020 Aug;8(16):1023. doi: 10.21037/atm-20-2874.